Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jun R Chiong

Showing results (1-10 of 24) with videos related to

Pageof 3
Sort By:
International Journal of Cardiology|January 15, 2008
Controlling hypertension from a public health perspectiveJun R Chiong
Korean Circulation Journal|June 12, 2013
Long-term anticoagulation in the extreme elderly with the newer antithrombotics: safe or sorry?Jun R Chiong, Rebecca J Cheung
Journal of the Renin-Angiotensin-Aldosterone System : JRAAS|September 14, 2002
Renin-angiotensin system antagonism and lipid-lowering therapy in cardiovascular risk managementJun R Chiong, Alan B Miller
Clinical Cardiology|June 18, 2010
Loop diuretic therapy in heart failure: the need for solid evidence on a fluid issueJun R Chiong, Rebecca J Cheung
Expert Opinion on Investigational Drugs|October 2, 2003
Agents that stabilise atherosclerotic plaqueJun R Chiong, Alan B Miller
Clinical Cardiology|November 20, 2010
Hyponatremia in acute decompensated heart failure: mechanisms, prognosis, and treatment optionsGeoffrey T Jao, Jun R Chiong
International Journal of Nephrology and Renovascular Disease|June 23, 2011
Clinical utility of tolvaptan in the management of hyponatremia in heart failure patientsSavina Nodari, Geoffrey T Jao, Jun R Chiong
Heart Failure Reviews|April 11, 2009
Clinical applications of N-terminal pro B-type natriuretic peptide in heart failure and other cardiovascular diseasesDa-Rong Pu, Jun R Chiong, Qi-chang Zhou
Heart Failure Reviews|April 11, 2009
Utility of natriuretic peptide testing in the evaluation and management of acute decompensated heart failureJun R Chiong, Geoffrey T Jao, Kirkwood F Adams
Hospital Practice (1995)|March 13, 2012
Evaluation of costs associated with tolvaptan-mediated hospital length of stay reduction among US patients with the syndrome of inappropriate antidiuretic hormone secretion, based on SALT-1 and SALT-2 trialsJoseph F Dasta, Jun R Chiong, Rudell Christian, et al.
Pageof 3

Showing results (1-10 of 24) with videos related to

Sort By:
Pageof 3
International Journal of Cardiology|January 15, 2008
Controlling hypertension from a public health perspectiveJun R Chiong
Korean Circulation Journal|June 12, 2013
Long-term anticoagulation in the extreme elderly with the newer antithrombotics: safe or sorry?Jun R Chiong, Rebecca J Cheung
Journal of the Renin-Angiotensin-Aldosterone System : JRAAS|September 14, 2002
Renin-angiotensin system antagonism and lipid-lowering therapy in cardiovascular risk managementJun R Chiong, Alan B Miller
Clinical Cardiology|June 18, 2010
Loop diuretic therapy in heart failure: the need for solid evidence on a fluid issueJun R Chiong, Rebecca J Cheung
Expert Opinion on Investigational Drugs|October 2, 2003
Agents that stabilise atherosclerotic plaqueJun R Chiong, Alan B Miller
Clinical Cardiology|November 20, 2010
Hyponatremia in acute decompensated heart failure: mechanisms, prognosis, and treatment optionsGeoffrey T Jao, Jun R Chiong
International Journal of Nephrology and Renovascular Disease|June 23, 2011
Clinical utility of tolvaptan in the management of hyponatremia in heart failure patientsSavina Nodari, Geoffrey T Jao, Jun R Chiong
Heart Failure Reviews|April 11, 2009
Clinical applications of N-terminal pro B-type natriuretic peptide in heart failure and other cardiovascular diseasesDa-Rong Pu, Jun R Chiong, Qi-chang Zhou
Heart Failure Reviews|April 11, 2009
Utility of natriuretic peptide testing in the evaluation and management of acute decompensated heart failureJun R Chiong, Geoffrey T Jao, Kirkwood F Adams
Hospital Practice (1995)|March 13, 2012
Evaluation of costs associated with tolvaptan-mediated hospital length of stay reduction among US patients with the syndrome of inappropriate antidiuretic hormone secretion, based on SALT-1 and SALT-2 trialsJoseph F Dasta, Jun R Chiong, Rudell Christian, et al.
Pageof 3